Ablation of EZH2 methyltransferase activity using both UNC1999 and GSK343 reduced the viability of MM cell lines in a dose- and time-dependent manner (Figure 3A and 3B and Figure S2). The gene discussed is EZH2; the disease is Miyoshi myopathy.